Home

scuti entuziast Ploios asca tumor marker Suri Sigur plan de vânzări

Serological markers of inflammatory bowel disease - Biochemia Medica
Serological markers of inflammatory bowel disease - Biochemia Medica

Antibodies Against Laminaribioside and Chitobioside Are Novel Serologic  Markers in Crohn's Disease - Gastroenterology
Antibodies Against Laminaribioside and Chitobioside Are Novel Serologic Markers in Crohn's Disease - Gastroenterology

SCREENING TESTS: Tumour Markers PSA Screening Bowel Cancer Screening QUIZ  FEEDBACK: Investigating the gut
SCREENING TESTS: Tumour Markers PSA Screening Bowel Cancer Screening QUIZ FEEDBACK: Investigating the gut

Results for 25 sera that were ASCA negative/OmpC positive as determined...  | Download Table
Results for 25 sera that were ASCA negative/OmpC positive as determined... | Download Table

Lecture 17 Colon Disorders - Pathology
Lecture 17 Colon Disorders - Pathology

Marker antibody expression stratifies Crohn's disease into immunologically  homogeneous subgroups with distinct clinical characteristics | Gut
Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics | Gut

Study of correlation between ASCA status and CD clinical features. |  Download Table
Study of correlation between ASCA status and CD clinical features. | Download Table

Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing  spondylitis and undifferentiated spondyloarthropathy | Annals of the  Rheumatic Diseases
Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy | Annals of the Rheumatic Diseases

Serologic testing of a panel of five antibodies in inflammatory bowel  diseases: Diagnostic value and correlation with disease phenotype
Serologic testing of a panel of five antibodies in inflammatory bowel diseases: Diagnostic value and correlation with disease phenotype

Summary of the diagnostic performance of ASCA in autoimmune disease |  Download Scientific Diagram
Summary of the diagnostic performance of ASCA in autoimmune disease | Download Scientific Diagram

Marker antibody expression stratifies Crohn's disease into immunologically  homogeneous subgroups with distinct clinical characteristics | Gut
Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics | Gut

IJMS | Free Full-Text | Correlation between Antibodies to Bacterial  Lipopolysaccharides and Barrier Proteins in Sera Positive for ASCA and ANCA  | HTML
IJMS | Free Full-Text | Correlation between Antibodies to Bacterial Lipopolysaccharides and Barrier Proteins in Sera Positive for ASCA and ANCA | HTML

Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing  spondylitis and undifferentiated spondyloarthropathy | Annals of the  Rheumatic Diseases
Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy | Annals of the Rheumatic Diseases

Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel  Diseases Up to 5 Years Before Diagnosis - Gastroenterology
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis - Gastroenterology

Relationship between ALCA, ACCA and ASCA in the CD cohort by presence... |  Download Scientific Diagram
Relationship between ALCA, ACCA and ASCA in the CD cohort by presence... | Download Scientific Diagram

Serological markers of inflammatory bowel disease - Biochemia Medica
Serological markers of inflammatory bowel disease - Biochemia Medica

Serological markers of inflammatory bowel disease - Biochemia Medica
Serological markers of inflammatory bowel disease - Biochemia Medica

ASCA results for 29 discrepant sera from two different laboratories |  Download Table
ASCA results for 29 discrepant sera from two different laboratories | Download Table

Anti‐Saccharomyces cerevisiae antibodies and response to infliximab in  refractory Crohn's disease - Schröder - 2004 - Alimentary Pharmacology  & Therapeutics - Wiley Online Library
Anti‐Saccharomyces cerevisiae antibodies and response to infliximab in refractory Crohn's disease - Schröder - 2004 - Alimentary Pharmacology & Therapeutics - Wiley Online Library

Cancers | Free Full-Text | Subcellular Expression of Maspin in Colorectal  Cancer: Friend or Foe | HTML
Cancers | Free Full-Text | Subcellular Expression of Maspin in Colorectal Cancer: Friend or Foe | HTML

Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic  Inflammatory Gastrointestinal and Liver Diseases - ScienceDirect
Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver Diseases - ScienceDirect

The gut mycobiome in health, disease, and clinical applications in  association with the gut bacterial microbiome assembly - The Lancet Microbe
The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly - The Lancet Microbe

Clinical Characteristics of ASCA-positive and ASCA- negative CD disease...  | Download Table
Clinical Characteristics of ASCA-positive and ASCA- negative CD disease... | Download Table